Organogenesis Holdings Inc. financial data

Symbol
ORGO on Nasdaq
Location
Canton, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 373% % 32%
Quick Ratio 43% % 27%
Debt-to-equity 44% % -32%
Return On Equity 0.4% %
Return On Assets 0.21% %
Operating Margin -1.8% % 36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,912,142 shares -4.3%
Common Stock, Shares, Outstanding 126,911,442 shares -4.3%
Entity Public Float $199,900,000 USD -15%
Common Stock, Value, Issued $13,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 126,881,709 shares -4.3%
Weighted Average Number of Shares Outstanding, Diluted 130,848,995 shares -2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $465,218,000 USD 2.2%
Cost of Revenue $110,768,000 USD 2%
Research and Development Expense $45,786,000 USD -9.4%
Operating Income (Loss) $8,376,000 USD 34%
Nonoperating Income (Expense) $2,172,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,204,000 USD 58%
Income Tax Expense (Benefit) $7,209,000 USD 3.6%
Net Income (Loss) Attributable to Parent $1,005,000 USD 75%
Earnings Per Share, Basic 0 USD/shares -83%
Earnings Per Share, Diluted 0 USD/shares -83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $63,745,000 USD -32%
Accounts Receivable, after Allowance for Credit Loss, Current $168,783,000 USD 67%
Inventory, Net $39,583,000 USD 46%
Assets, Current $299,749,000 USD 26%
Deferred Income Tax Assets, Net $45,591,000 USD 27%
Property, Plant and Equipment, Net $78,058,000 USD -13%
Operating Lease, Right-of-Use Asset $33,304,000 USD -4.7%
Intangible Assets, Net (Excluding Goodwill) $9,943,000 USD -25%
Goodwill $28,772,000 USD 0%
Other Assets, Noncurrent $14,410,000 USD 187%
Assets $509,827,000 USD 14%
Accounts Payable, Current $40,219,000 USD 68%
Employee-related Liabilities, Current $31,413,000 USD 38%
Accrued Liabilities, Current $40,310,000 USD 12%
Liabilities, Current $90,319,000 USD 17%
Operating Lease, Liability, Noncurrent $23,507,000 USD 3.2%
Other Liabilities, Noncurrent $2,509,000 USD 94%
Liabilities $123,848,000 USD -26%
Retained Earnings (Accumulated Deficit) $46,778,000 USD 2.1%
Stockholders' Equity Attributable to Parent $255,128,000 USD -8.4%
Liabilities and Equity $509,827,000 USD 14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,935,000 USD -96%
Net Cash Provided by (Used in) Financing Activities $2,056,000 USD 21%
Net Cash Provided by (Used in) Investing Activities $3,626,000 USD -63%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 127,639,990 shares -4.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,617,000 USD -71%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64,372,000 USD -32%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,375,000 USD 8.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $49,995,000 USD 21%
Operating Lease, Liability $138,356,000 USD 176%
Depreciation $14,822,000 USD 14%
Payments to Acquire Property, Plant, and Equipment $3,626,000 USD 63%
Lessee, Operating Lease, Liability, to be Paid $146,686,000 USD 152%
Property, Plant and Equipment, Gross $134,619,000 USD -6.8%
Operating Lease, Liability, Current $4,785,000 USD 22%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $1,266,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,330,000 USD 4.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 870,000 shares -13%
Unrecognized Tax Benefits $873,000 USD -46%
Operating Lease, Payments $2,715,000 USD 10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $3,359,000 USD -12%
Depreciation, Depletion and Amortization $13,995,000 USD 12%
Deferred Tax Assets, Net of Valuation Allowance $39,462,000 USD 41%
Interest Expense $2,081,000 USD 17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%